We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.1B
AUM Growth
+$2.29B
Cap. Flow
+$1.49B
Cap. Flow %
8.21%
Top 10 Hldgs %
14.26%
Holding
1,826
New
616
Increased
338
Reduced
371
Closed
491

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$219M
2
TWX
Time Warner Inc
TWX
+$207M
3
DGX icon
Quest Diagnostics
DGX
+$161M
4
CVS icon
CVS Health
CVS
+$154M
5
PCG icon
PG&E
PCG
+$143M

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$162M
2
TXN icon
Texas Instruments
TXN
+$103M
3
AMZN icon
Amazon
AMZN
+$85.6M
4
DAL icon
Delta Air Lines
DAL
+$76M
5
NVDA icon
NVIDIA
NVDA
+$75.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.56%
2 Technology 14.21%
3 Consumer Discretionary 12.36%
4 Industrials 10.91%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVGO icon
26
Broadcom
AVGO
$1.87T
$116M 0.64%
4,518,380
+1,701,590
+60% +$44.2M
CSGP icon
27
CoStar Group
CSGP
$12.2B
$114M 0.63%
3,851,080
+1,110,380
+41% +$32.5M
PCG icon
28
PG&E
PCG
$38.4B
$114M 0.63%
+2,548,048
New +$143M
DRI icon
29
Darden Restaurants
DRI
$23.6B
$111M 0.61%
1,157,599
+744,422
+180% +$62.9M
MU icon
30
Micron Technology
MU
$937B
$107M 0.59%
2,613,367
+1,209,366
+86% +$52.1M
IDXX icon
31
Idexx Laboratories
IDXX
$44.8B
$107M 0.59%
683,294
+437,667
+178% +$68.9M
SAGE
32
DELISTED
Sage Therapeutics
SAGE
$105M 0.58%
637,017
+580,056
+1,018% +$56.2M
KEYS icon
33
Keysight
KEYS
$55B
$104M 0.58%
2,507,501
-1,302,405
-34% -$56.3M
NOW icon
34
ServiceNow
NOW
$118B
$104M 0.57%
3,977,455
+3,268,240
+461% +$81.3M
PANW icon
35
Palo Alto Networks
PANW
$283B
$95.7M 0.53%
3,962,058
+252,516
+7% +$6.14M
USFD icon
36
US Foods
USFD
$21.9B
$92.9M 0.51%
+2,910,480
New +$82.4M
ITW icon
37
Illinois Tool Works
ITW
$83B
$92.5M 0.51%
554,685
+465,137
+519% +$74.2M
ABMD
38
DELISTED
Abiomed Inc
ABMD
$89.5M 0.49%
477,618
+346,758
+265% +$64.7M
ROST icon
39
Ross Stores
ROST
$81.1B
$89.5M 0.49%
1,115,101
-809,932
-42% -$56.6M
BERY
40
DELISTED
Berry Global Group, Inc.
BERY
$88.1M 0.49%
1,635,541
+119,366
+8% +$6.49M
BKNG icon
41
Booking.com
BKNG
$149B
$86.8M 0.48%
1,249,300
+436,000
+54% +$31.6M
GSK icon
42
GSK
GSK
$103B
$86.2M 0.48%
1,943,388
+381,165
+24% +$17.6M
MFC icon
43
Manulife Financial
MFC
$74B
$83.9M 0.46%
4,011,754
+3,316,633
+477% +$68.9M
BIIB icon
44
Biogen
BIIB
$29.8B
$81.6M 0.45%
255,998
+16,582
+7% +$5.32M
ESRX
45
DELISTED
Express Scripts Holding Company
ESRX
$80.1M 0.44%
+1,073,546
New +$68.7M
FRC
46
DELISTED
First Republic Bank
FRC
$76.5M 0.42%
883,151
+121,209
+16% +$11.5M
EA icon
47
Electronic Arts
EA
$53B
$74.8M 0.41%
711,570
+360,184
+103% +$40M
AMTD
48
DELISTED
TD Ameritrade Holding Corp
AMTD
$73.5M 0.41%
+1,438,336
New +$71.9M
J icon
49
Jacobs Solutions
J
$16.4B
$73.4M 0.41%
1,344,957
-2,864
-0.2% -$147K
TRI icon
50
Thomson Reuters
TRI
$44.4B
$73.3M 0.41%
1,447,402
+818,183
+130% +$42.8M
1
2
3 4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2017 Portfolio in Review

As of Q4 2017, Marshall Wace North America held 1,826 positions worth $18.1B, up 14% from $15.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.49B of net new capital in Q4 2017, opening 616 new positions and adding to 338 existing holdings. Its largest new stake was Time Warner Inc: 2,188,772 shares worth $200M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Applied Materials, an estimated $162M trimmed.

  • Marshall Wace North America's largest Q4 2017 buy was Time Warner Inc: 2,188,772 shares worth $200M.
  • Marshall Wace North America added most to Boston Scientific in Q4 2017, an estimated $219M increase.
  • Marshall Wace North America's biggest Q4 2017 reduction was Applied Materials, cutting an estimated $162M.
  • Marshall Wace North America fully exited NVIDIA in Q4 2017, selling an estimated $75.7M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $18.1B portfolio in Q4 2017.
  • Marshall Wace North America opened 616 new positions and closed 491 in Q4 2017.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $18.1B.

Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.